Insys Therapeutics Incorporated operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Insys Therapeutics Incorporated with three other
companies in this sector in the United States:
sales of $237.71 million
Albany Molecular Research Incorporated
of which 54%
was API), and
Five Prime Therapeutics Inc